Condition

Rifampicin Resistant Tuberculosis clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• JDB0131 tablets for drug-resistant pulmonary TB

  This tests two doses of the experimental tablet JDB0131 versus a delamanid-containing regimen in people aged 14–65 with rifampicin-resistant or multidrug-resistant pulmonary tuberculosis over an 8-week treatment period.

  Recruiting at 6 sites Phase 2 WestVac Biopharma Co., Ltd. · Wuhan, Hubei and 6 other locations · NCT07170800

• New all-oral treatment for rifampicin-resistant tuberculosis

  This study is testing seven new all-oral treatment options for people with rifampicin-resistant tuberculosis to see if they work better than the standard treatment.

  Recruiting at 5 sites Phase 3 Huashan Hospital · Guiyang, Guizhou and 4 other locations · NCT05081401

Related topics

Quick answers

How many Rifampicin Resistant Tuberculosis clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →